Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In silico exploration of anti-prostate cancer compounds from differential expressed genes

3 Jul 2024

Abstract excerpt

Abstract Prostate cancer (PCa) is a complex and biologically diverse disease with no curative treatment options at present. This study aims to utilize computational methods to explore potential anti-PCa compounds based on differentially expressed genes (DEGs), with the goal of identifying novel therapeutic indications or repurposing existing drugs. The methods employed in this study include DEGs-to-drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Computational Drug Discovery Methods
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38956591
DOI: 10.1186/s12894-024-01521-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In silico exploration of anti-prostate cancer compounds from differential expressed genesPMID 38956591Read ↗

Identification of Differentially Expressed Genes and Drug Targets in Prostate Cancer Using Next-Generation SequencingSemantic proximity Read ↗

Bioinformatics and system biology approaches for identifying potential therapeutic targets for prostate cancerSemantic proximity Read ↗

Network Analysis of Genes and Identification of Candidate Drug Compounds for Associated Deadly Diseases of FemalesSemantic proximity Read ↗

Identification and Validation of Four Novel Biomarkers Involved in Docetaxel Resistant Prostate CancerSemantic proximity Read ↗

Integrative genomic and bioinformatic prioritization of drug repurposing candidates for prostate cancer.Semantic proximity Read ↗

Network Analysis of Genes and Identification of Candidate Drug Compound for Associated Deadly Diseases of FemaleSemantic proximity Read ↗

Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glanceSemantic proximity Read ↗

Disease mechanism, drug-target and biomarker prediction software: Application on prostate cancer and validationSemantic proximity Read ↗

Evaluating Gliclazide as a Safer Alternative Treatment for Castration- Resistant Prostate Cancer via lncRNA-Mediated Androgen Receptor InteractionsSemantic proximity Read ↗

Distinct druggable biological processes in early-onset prostate cancerSemantic proximity Read ↗

Identifying Potential Drug Targets for Prostate Cancer from a Genetic Perspective: A Mendelian Randomization StudySemantic proximity Read ↗

The cornerstone of early diagnosis and immunotherapy of prostate cancer:screening characteristic genesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.